Lucid Diagnostics Receives Nasdaq Notice for Failing Minimum Bid Price Requirement

• Lucid Diagnostics received a Nasdaq noncompliance notice on October 12, 2026, for breaching Listing Rule 5550(a)(2)'s $1 minimum bid price requirement.
• Common stock closed below $1 for 30 consecutive business days through October 9, 2026; the compliance deadline is April 12, 2027.
• The initial compliance period spans 180 calendar days; regaining compliance requires closing bids of at least $1 for 10 consecutive business days.
• An additional 180-day extension may be available; otherwise, delisting could follow if eligibility requirements are unmet or Nasdaq considers remediation unlikely.
• Trading continues uninterrupted under LUCD; the notice has no immediate effect on the common stock's listing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lucid Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-047404), on October 16, 2026, and is solely responsible for the information contained therein.